Cell and Gene Therapy Manufacturing Services Market 2028 By Type, Indication, Application, End Use, and Geography | The Insight Partners

report image

Cell and Gene Therapy Manufacturing Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Allogeneic, Autologous, Viral Vector, and Non-Viral Vector); Indication (Cancer, and Orthopedic); Application (Clinical, Commercial, and Others); End Use (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End Users), and Geography

Report Code: TIPRE00024304 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Cell therapy is one of the most encouraging healthcare procedures for the restoration of damaged tissue. Cell therapies have enormous potential for many disease treatments, including tissue degradation, immune deficiency, metabolic disorders, and cancer. Cell therapy is categorized into two type's allogeneic (cells from a third-party donor) and autologous (cells from one's own body). Cell therapy has gained significant traction in the recent past, and currently, it is under commercial development. The main objective of cell therapy is to re-establish the lost function of tissues and cells rather than to produce a new organ. Gene therapy is a procedure that alters a person's genes to treat or cure a disease. Gene therapies can work by multiple mechanisms: Replacing a disease-causing gene with a healthy copy of the gene and inactivating a disease-causing gene that is not functioning correctly. There are two gene therapy treatments: somatic cell gene therapy and germline therapy.


The "Global Cell & Gene Therapy Manufacturing Services Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Cell & Gene therapy manufacturing services market with detailed market segmentation by type, indication, application, end use, and geography. The report provides key statistics on the market status of the leading Cell & Gene therapy manufacturing services market players and offers key trends and opportunities in the market.


  •  Based on type, the global Cell & Gene therapy manufacturing services market is segmented into allogeneic, autologous, viral vector, non-viral vector.
  •  On the basis of indication, the market is segmented into cancer, orthopedic.
  •  On the basis of application, the market is segmented into clinical, commercial, others.
  •  On the basis of end use, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, other end users.


  •  Rise in the incidences of cancer and other target diseases.
  •  Technological advancements by CDMOs.
  •  Growth in the investments in pharmaceutical R&D.


  •  The high operational costs associated with cell & gene therapy manufacturing is the major restraining factor for this market.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Cell & Gene therapy manufacturing services market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Cell & Gene therapy manufacturing services market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the Cell & Gene therapy manufacturing services market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Cell & Gene therapy manufacturing services market are anticipated to lucrative growth opportunities in the future with the rising demand for Cell & Gene therapy manufacturing services in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Cell & Gene therapy manufacturing services market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Thermo Fisher Scientific
  •  Merck KGaA
  •  Charles River Laboratories
  •  Lonza
  •  Catalent
  •  WuXi AppTec
  •  Takara Bio Inc.
  •  Nikon Corporation
  •  FUJIFILM Holdings Corporation
  •  F. Hoffmann-La Roche Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Thermo Fisher Scientific
2. Merck KGaA
3. Charles River Laboratories
4. Lonza
5. Catalent
6. WuXi AppTec
7. Takara Bio Inc.
8. Nikon Corporation
9. FUJIFILM Holdings Corporation
10. F. Hoffmann-La Roche Ltd.
11. Oxford Biomedica plc
12. Cell and Gene Therapy Catapult
13. The Discovery Labs LLC
14. RoslinCT
16. FinVector
17. ABL, Inc.
18. Resilience
19. BioCentriq
20. Porton Biopharma Limited
21. Andelyn Biosciences
22. Commercializing Living Therapies
23. Vibalogics
24. Anemocyte Srl
25. ElevateBio
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount